Cargando…
Glioblastoma Stem-Like Cells (GSCs) with Mesenchymal Signature: Lipid Profiles of Mobile Lipids Obtained with MRS before and after Radio/Chemical Treatments
Glioblastoma is the most common and lethal primary malignant brain tumor in adults. Glioblastoma stem cells (GSCs) promote and are responsible for glioblastoma intratumoral heterogeneity and therapy resistance, due to their two main features: self-renewal and differentiation. Lipids have important b...
Autores principales: | Grande, Sveva, Palma, Alessandra, Luciani, Anna Maria, Anello, Pasqualino, Ricci-Vitiani, Lucia, Buccarelli, Mariachiara, D’Alessandris, Quintino Giorgio, Pallini, Roberto, Guidoni, Laura, Viti, Vincenza, Rosi, Antonella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405836/ https://www.ncbi.nlm.nih.gov/pubmed/36008944 http://dx.doi.org/10.3390/biom12081051 |
Ejemplares similares
-
Metabolic Heterogeneity Evidenced by MRS among Patient-Derived Glioblastoma Multiforme Stem-Like Cells Accounts for Cell Clustering and Different Responses to Drugs
por: Grande, Sveva, et al.
Publicado: (2018) -
Different Mechanisms Underlie the Metabolic Response of GBM Stem-Like Cells to Ionizing Radiation: Biological and MRS Studies on Effects of Photons and Carbon Ions
por: Palma, Alessandra, et al.
Publicado: (2020) -
Effects of the Combined Treatment with a G-Quadruplex-Stabilizing Ligand and Photon Beams on Glioblastoma Stem-like Cells: A Magnetic Resonance Study
por: Palma, Alessandra, et al.
Publicado: (2021) -
A three‐microRNA signature identifies two subtypes of glioblastoma patients with different clinical outcomes
por: Marziali, Giovanna, et al.
Publicado: (2017) -
Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice
por: Ceruti, Tommaso, et al.
Publicado: (2022)